Evidence map›Paper›PMID 41596519›Full record

ReviewInternational journal of molecular sciences2026

Chronic Pain in Multiple Sclerosis: Mechanisms, Clinical Characteristics and Treatment Strategies.

Panagiotis Gklinos, Georgia Christodoulou, Dorothea Pournara, Maria-Eleftheria Evangelopoulos, Dimos-Dimitrios Mitsikostas

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Panagiotis Gklinos1st Department of Neurology, Eginition University Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece.ORCID 0000-0001-5022-6460
Georgia Christodoulou1st Department of Neurology, Eginition University Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece.
Dorothea Pournara1st Department of Neurology, Eginition University Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece.
Maria-Eleftheria Evangelopoulos1st Department of Neurology, Eginition University Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece.ORCID 0000-0003-4654-7477
Dimos-Dimitrios Mitsikostas1st Department of Neurology, Eginition University Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece.ORCID 0000-0002-4691-3388

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic pain is an underestimated and undertreated yet highly prevalent symptom in people with multiple sclerosis (pwMS), significantly impairing quality of life and functional outcomes. Its prevalence ranges from 23% to 90% across studies, reflecting methodological differences and discrepancies in the definition and recognition of chronic pain. In this article, we aim to provide an updated review of the pathophysiological mechanisms of chronic pain in MS, including the effect and interaction between neuropathic, nociceptive and nociplastic mechanisms, and propose a mechanism-based classification. Furthermore, we explore different therapeutic approaches, including both pharmacological and non-pharmacological interventions, tailored to each patient according to the mechanism involved. A deeper understanding of the distinct chronic pain mechanisms and phenotypes can provide more effective and personalized treatment strategies and lead to improved patient outcomes and quality of life.

Indexed as

Chronic PainMultiple SclerosisHumansNociplastic PainPain ManagementQuality of Lifechronic painmultiple sclerosispainpathogenesisreviewtreatment

Identifiers

PMID41596519
PMCPMC12841355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.